Hilfe Warenkorb Konto Anmelden
 
 
   Schnellsuche   
     zur Expertensuche                      
The Bionic Human - Health Promotion for People with Implanted Prosthetic Devices
  Großes Bild
 
The Bionic Human - Health Promotion for People with Implanted Prosthetic Devices
von: Frank E Johnson, Katherine Virgo
Humana Press, 2007
ISBN: 9781592599752
706 Seiten, Download: 6368 KB
 
Format:  PDF
geeignet für: Apple iPad, Android Tablet PC's Online-Lesen PC, MAC, Laptop

Typ: B (paralleler Zugriff)

 

 
eBook anfordern
Inhaltsverzeichnis

  Foreword 5  
  Preface 6  
  Contents 7  
  Contributors 11  
  Overview 15  
     APPENDIX 21  
     APPENDIX (Continued) 22  
     APPENDIX (Continued) 23  
     APPENDIX (Continued) 24  
     APPENDIX (Continued) 25  
     REFERENCES 26  
  Assessment of Surveillance Test Performance and Cost 27  
     EPIDEMIOLOGICAL PRINCIPLES FOR EVALUATING DIAGNOSTIC TEST PERFORMANCE IN SCREENING FOR DEVICE MALFUNCTION OR INFECTION Overview 28  
     DIAGNOSTIC TEST CHARACTERISTICS Validity 28  
     LIKELIHOOD RATIOS 31  
     REQUIREMENTS FOR ESTABLISHING A SCREENING PROGRAM 32  
     RECEIVER OPERATING CHARACTERISTIC CURVE 32  
     THRESHOLDS FOR TREATMENT 33  
     THRESHOLDS FOR TESTING 34  
     ECONOMIC PRINCIPLES OF FOLLOW-UP EVALUATION Overview of Cost Analysis 36  
     SUMMARY 44  
     REFERENCES 44  
  Costs of Follow-Up After Implantation of Prosthetic Devices 47  
     METHODS 48  
     RESULTS 49  
     COMMENT 57  
     REFERENCES 59  
  Factors That Should Shape Clinical Strategies 60  
     ETHICAL AND LEGAL ISSUES 67  
     DURATION OF SURVEILLANCE 68  
     SECONDARY BENEFITS OF FOLLOW-UP 68  
     PRIMARY PREVENTION OF DISEASE 68  
     SUMMARY 71  
     REFERENCES 72  
  A View From the US Food and Drug Administration* 74  
     INTRODUCTION 74  
     PREMARKET REVIEW Background 76  
     POSTMARKET OVERSIGHT Overview 86  
     SPECIAL TOPICS Access to Information 95  
     REFERENCES 98  
  Societal Issues 101  
     TECHNOLOGY AND SOCIETY 101  
     TECHNOLOGY AND HISTORY 101  
     COSTS 102  
     MANAGED CARE 103  
     IMPLANTED TECHNOLOGY 104  
     BREAST IMPLANTS Background 104  
     THE BJORK-SHILEY CONVEXO-CONCAVE ARTIFICIAL HEART VALVE Background 108  
     COCHLEAR IMPLANTS (40)* Background 118  
     THE TOTAL ARTIFICIAL HEART Background 120  
     SOCIETAL ISSUES IN IMPLANTED MEDICAL DEVICES 123  
     PROFESSIONAL AND CONSUMER MODELS OF HEALTH CARE 124  
     REFERENCES 124  
  Databases for Studying the Epidemiology of Implanted Medical Devices* 127  
     INTRODUCTION 127  
     SYSTEMATIC NEW DATA COLLECTION 128  
     GATHERING AND SYNTHESIS OF EXISTING PATIENT DATA AND STUDIES 131  
     FUTURE OF DATABASES FOR STUDYING THE EPIDEMIOLOGY OF IMPLANTED DEVICES Increasing Technological Sophistication of Patient Data 139  
     ACKNOWLEDGMENT 140  
     REFERENCES 140  
  Tissue Reaction to Prosthetic Materials 145  
     INTRODUCTION 145  
     MATERIALS USED IN PROSTHESES 146  
     MOLECULAR AND CELLULAR EVENTS OF HOMEOSTASIS 154  
     HISTOPATHOLOGY OF EXPLANTED PROSTHESES Dental 159  
     FUTURE TRENDS IN PROSTHETIC DESIGN 165  
     REFERENCES 165  
  Prevention of Infection in Prosthetic Devices 171  
     INTRODUCTION 171  
     GENERAL PRINCIPLES OF INFECTION PREVENTION IN PROSTHETIC DEVICES Preoperative Measures 173  
     INDIVIDUAL CHARACTERISTICS OF THE MOST COMMONLY USED PROSTHETIC DEVICES Breast Implants 176  
     SUMMARY 190  
     REFERENCES 193  
  European Counterpoint to Chapter 9 198  
     INTRODUCTION 198  
     THE ROLE OF PROPHYLACTIC ANTIBIOTICS 199  
     PATIENT FACTORS THAT CONTRIBUTE TO INFECTION OF PROSTHESES 200  
     VENTRICULOPERITONEAL SHUNTS 200  
     PENILE PROSTHESIS 202  
     JOINT PROSTHESES 204  
     MESH REPAIRS OF HERNIAS 206  
     VASCULAR GRAFTS 207  
     BREAST IMPLANTS 208  
     PROSTHETIC CARDIAC VALVES 209  
     COCHLEAR IMPLANTS 210  
     COMMENTS 212  
     REFERENCES 213  
  Computer Modeling 216  
     INTRODUCTION 216  
     EXAMPLE 1: A DECISION TREE FOR A DIAGNOSTIC PROBLEM 217  
     EXAMPLE 2: A STATE-TRANSITION MODEL FOR A PROGNOSTIC PROBLEM 217  
     EXAMPLE 3: A MODEL FOR A FOLLOW-UP SCHEME 217  
     DECISION TREES 217  
     EXAMPLE 1: BREAST IMPLANTS 218  
     STATE-TRANSITION MODELS 225  
     EXAMPLE 2: BJÖRK-SHILEY CONVEXO- CONCAVE HEART VALVE PATIENTS 229  
     EXAMPLE 3: EVALUATION OF FOLLOW-UP SCHEMES 232  
     GENERAL MODELING ISSUES 234  
     VALIDITY AND CREDIBILITY 235  
     SUMMARY AND CONCLUSION 237  
     FURTHER READING 238  
     REFERENCES 238  
  Breast Prostheses 241  
     INTRODUCTION 241  
     MAMMOGRAPHY 252  
     ULTRASOUND 253  
     MAGNETIC RESONANCE IMAGING 253  
     COMPUTED TOMOGRAPHY 254  
     ENDOSCOPY 254  
     CAPSULAR CONTRACTURE 254  
     ACKNOWLEDGMENTS 258  
     APPENDIX: SUPPORT GROUPS 258  
     APPENDIX: SUPPORT GROUPS ( CONTINUED) 259  
     REFERENCES 259  
  US Counterpoint to Chapter 11 265  
     INTRODUCTION 265  
     REFERENCES 267  
  European Counterpoint to Chapter 11 269  
     USE OF BREAST IMPLANTS IN THE UNITED KINGDOM 269  
     BREAST AUGMENTATION 271  
     INFECTION AND BREAST IMPLANTS 273  
     CAPSULAR CONTRACTURE 274  
     APPENDIX: SOURCES OF ADDITIONAL INFORMATION 277  
     REFERENCES 278  
     APPENDIX: SOURCES OF ADDITIONAL INFORMATION (Continued) 278  
  Prostheses for Hernia Repair 280  
     INTRODUCTION 280  
     PROSTHETIC FAILURE AND INFECTION 283  
     PREVENTIVE MEASURES 284  
     REFERENCES 284  
  US Counterpoint to Chapter 12 286  
     INGUINAL HERNIA REPAIR 286  
     INCISIONAL HERNIA REPAIR 288  
     OTHER ABDOMINAL WALL HERNIAS 290  
     SUMMARY 291  
     REFERENCES 291  
  European Counterpoint to Chapter 12 293  
     PROSTHESES FOR HERNIA REPAIR 293  
     IMPORTANCE OF PROSTHESIS DESIGN AND QUALITY OF MANUFACTURE 294  
     PREVENTIVE MEASURES 295  
     REFERENCES 295  
  Penile Prostheses 297  
     INTRODUCTION 297  
     APPENDIX A: ORGANIZATIONS WITH ERECTILE DYSFUNCTION INFORMATION 305  
     APPENDIX A: ORGANIZATIONS WITH ERECTILE DYSFUNCTION INFORMATION (Continued) 306  
     PROSTATE CANCER SURVIVORS GROUPS: 306  
     APPENDIX B: VENDORS OF PENILE IMPLANTS IN THE UNITED STATES 306  
     REFERENCES 306  
  US Counterpoint to Chapter 13 308  
     INTRODUCTION 308  
     REFERENCE 309  
  European Counterpoint to Chapter 13 310  
     INTRODUCTION 310  
     SAFETY AND OUTCOME 311  
     INDICATIONS FOR IMPLANTING PENILE PROSTHESES 311  
     PROSTHETIC DESIGN/QUALITY OF MANUFACTURE 318  
     APPENDIX: SOURCES OF ADDITIONAL IINFORMATION 318  
     REFERENCES 319  
  Artificial Urethral Sphincters 321  
     INTRODUCTION 321  
     PUBLISHED GUIDELINES FOR FOLLOW-UP 323  
     DETECTION OF PROSTHETIC FAILURE 324  
     DETECTION OF PROGRESSION OF THE DISORDER FOR WHICH THE PROSTHESIS WAS PLACED 324  
     DETECTION OF OTHER CONDITIONS OF MEDICAL SIGNIFICANCE 325  
     WHAT IS KNOWN ABOUT ACTUAL STRATEGIES OF PRACTICING CLINICIANS? 325  
     IMPORTANCE OF PROSTHESIS DESIGN AND QUALITY OF MANUFACTURE 325  
     VARIATION IN FOLLOW-UP BY PROSTHETIC TYPE 326  
     ARE MULTICENTER PROSPECTIVE TRIALS NEEDED? 327  
     APPENDIX: SUPPORT GROUPS FOR PEOPLE WITH CONTINENCE- RELATED PROBLEMS 328  
     REFERENCES 328  
  US Counterpoint to Chapter 14 330  
     INTRODUCTION 330  
     REFERENCE 331  
  European Counterpoint to Chapter 14 332  
     FOLLOW-UP 336  
     FUTURE RESEARCH 337  
     APPENDIX: ADDITIONAL RESOURCES FOR INFORMATION ABOUT ARTIFICIAL URETHRAL SPHINCTERS 338  
     REFERENCES 338  
  Cerebrospinal Fluid Shunts 340  
     HISTORY 340  
     EPIDEMIOLOGY 342  
     PATHOPHYSIOLOGY 343  
     CSF SHUNT HYDRODYNAMICS 345  
     SHUNT COMPONENTS AND DESIGN 347  
     OPERATIVE PROCEDURES 351  
     FOLLOW-UP CARE 355  
     DIAGNOSIS AND TREATMENT OF SHUNT COMPLICATIONS 358  
     SUPPORT ORGANIZATIONS 360  
     APPENDIX: RECOMMENDED HYDROCEPHALUS SUPPORT ORGANIZATIONS 360  
     REFERENCES 361  
  US Counterpoint to Chapter 15 366  
     INTRODUCTION 366  
     APPENDIX: RESOURCES FOR LEARNING MORE ABOUT HYDROCEPHALUS 368  
     REFERENCES 369  
  European Counterpoint to Chapter 15 370  
     EPIDEMIOLOGY 370  
     EVOLUTION OF CLINICAL PRACTICE 372  
     FOLLOW-UP MANAGEMENT 373  
     DETECTION AND MANAGEMENT OF SHUNT INFECTION 376  
     PRIMARY AND SECONDARY PREVENTION 378  
     MULTI-INSTITUTION PROSPECTIVE TRIALS 379  
     APPENDIX: SUPPORT GROUPS IN EUROPE 380  
     REFERENCES 380  
  Cochlear Implants 386  
     HISTORICAL ASPECTS AND TRENDS 386  
     COCHLEAR IMPLANT COMPONENTS AND THEIR FUNCTIONS 388  
     CURRENTLY AVAILABLE COCHLEAR IMPLANTS IN THE UNITED STATES 389  
     MEDEL (MEDICAL ELECTRONICS) 394  
     PERFORMANCE OF DIFFERENT DEVICES 395  
     CANDIDACY, PREOPERATIVE PLANNING, AND SURGERY Indication 396  
     IMPORTANCE OF PROSTHETIC DESIGN 398  
     FOLLOW-UP CONSIDERATIONS 399  
     PROGRAMMING STRATEGIES OF PRACTICING CLINICIANS 400  
     SPECIAL PATIENT POPULATIONS 401  
     EXPECTATIONS AND RECOVERY STAGES 404  
     DELAYED COMPLICATIONS 404  
     SUPPORT GROUPS 406  
     APPENDIX: CONTACT INFORMATION FOR SUPPORT GROUPS 408  
     REFERENCES 409  
  US Counterpoint to Chapter 16 411  
     RESPONSIBILITY 411  
     EARLY PROBLEM DETECTION 412  
     LATE PROBLEM DETECTION 412  
     SUMMARY 413  
     REFERENCES 414  
  European Counterpoint to Chapter 16 415  
     INTRODUCTION 415  
     PREOPERATIVE ASSESSMENT 416  
     REFERENCES 418  
  Ossicular Implants 420  
     INTRODUCTION 420  
     BIOMATERIALS 421  
     TYPES OF OSSICULAR PROSTHESES 422  
     INDICATIONS FOR IMPLANTS 422  
     FOLLOW-UP 425  
     DETECTION OF COMPLICATIONS 425  
     PROSTHESES FOR STAPES SURGERY IN OTOSCLEROSIS 426  
     APPENDIX: WEB SITES FOR FURTHER INFORMATION 429  
     REFERENCES 429  
  US Counterpoint to Chapter 17 431  
     RESPONSIBILITY 431  
     EARLY PROBLEM DETECTION 432  
     LATE PROBLEM DETECTION 432  
     THINGS TO AVOID 433  
     SUMMARY 434  
     REFERENCES 435  
  European Counterpoint to Chapter 17 436  
     RECONSTRUCTIVE MIDDLE EAR SURGERY 436  
     POSTOPERATIVE SURVEILLANCE 439  
     REFERENCES 441  
  Vascular Prostheses 443  
     INTRODUCTION 443  
     GENERAL CONSIDERATIONS 443  
     CAROTID REVASCULARIZATION 447  
     HEMODIALYSIS ACCESS 451  
     RENOVASCULAR INTERVENTIONS 453  
     MESENTERIC ARTERY REVASCULARIZATION 455  
     INTERVENTIONS FOR AORTOILIAC OCCLUSIVE DISEASE 457  
     AORTIC ENDOGRAFTS 460  
     SURVEILLANCE AFTER PLACEMENT OF AORTIC ENDOGRAFTS 463  
     INFRAINGUINAL BYPASS GRAFTS 466  
     TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT 470  
     SUMMARY 472  
     REFERENCES 473  
  US Counterpoint to Chapter 18 479  
     INTRODUCTION 479  
  European Counterpoint to Chapter 18 486  
     INTRODUCTION 486  
     AORTIC AND SUPRAINGUINAL RECONSTRUCTION AND FOLLOW- UP OF ASYMPTOMATIC PATIENTS 488  
     INFRAINGUINAL BYPASS AND FOLLOW-UP IN ASYMPTOMATIC PATIENTS 490  
     CONCLUSION 492  
     REFERENCES 492  
  Cardiac Valves 494  
     INTRODUCTION 494  
     HISTORY OF HEART VALVE PROSTHESES 495  
     CLASSIFICATION OF PROSTHETIC HEART VALVES 496  
     MANAGEMENT OF THE PATIENT WITH A PROSTHETIC HEART VALVE 502  
     CHRONIC ANTICOAGULATION: THROMBOEMBOLIC RISK AND BLEEDING RISK 508  
     PROSTHETIC HEART VALVE DYSFUNCTION 513  
     EVALUATION AND TREATMENT OF CORONARY HEART DISEASE IN PATIENTS WITH PROSTHETIC VALVES 522  
     APPENDIX: RESOURCES FOR PHYSICIANS AND PATIENTS 523  
     REFERENCES 523  
  US Counterpoint to Chapter 19 528  
     APPENDIX: RESOURCES FOR PHYSICIANS AND PATIENTS 531  
     REFERENCES 531  
  European Counterpoint to Chapter 19 533  
     CURRENT PRACTICE 533  
     FOLLOW-UP AFTER MECHANICAL HEART VALVE REPLACEMENT 535  
     MANAGEMENT OF INFECTIONS AND PREVENTION OF PROSTHETIC VALVE ENDOCARDITIS 535  
     MANAGEMENT OF ANTICOAGULANTS 536  
     REFERENCES 537  
  Intravascular Filters and Stents 538  
     INTRODUCTION 538  
     VENA CAVAL FILTERS 538  
     ENDOVASCULAR STENTS 542  
     REFERENCES 545  
  US Counterpoint to Chapter 20 547  
     REFERENCES 550  
  European Counterpoint to Chapter 20 552  
     VENOUS STENTS 555  
     COMMENT 557  
     APPENDIX: 559  
     SPECIALIST 559  
     ORGANIZATIONS IN INTERVENTIONAL 559  
     RADIOLOGY 559  
     REFERENCES 561  
  Vascular Access Devices 565  
     HISTORY 565  
     SHORT-TERM, PERCUTANEOUS, NON- TUNNELED CENTRAL VENOUS CATHETERS 566  
     INTERMEDIATE-TERM CENTRAL VENOUS ACCESS DEVICES 568  
     LONG-TERM, SILASTIC, TUNNELED, CUFFED RIGHT ATRIAL CATHETERS 569  
     LONG-TERM SUBCUTANEOUS VENOUS ACCESS PORTS 569  
     IMPLANTABLE INFUSION PUMPS 573  
     CVC MAINTENANCE AND SURVEILLANCE FOR COMPLICATIONS 573  
     SURVEY OF OHIO SURGEONS WHO IMPLANT VENOUS ACCESS DEVICES 576  
     CVC SURVEILLANCE: CONTROVERSIES AND POTENTIAL FUTURE STUDIES Catheter- Associated Infection 581  
        Catheter Occlusion 583  
        Catheter Damage/Breakage 584  
        Venous Thrombosis and Stenosis 584  
     CONCLUSION 587  
     REFERENCES 587  
  US Counterpoint to Chapter 21 592  
     VASCULAR ACCESS DEVICES 592  
     REFERENCES 595  
  European Counterpoint to Chapter 21 597  
     BACKGROUND 597  
     PREVENTION AND TREATMENT OF COMPLICATIONS 598  
     SUMMARY 601  
     APPENDIX: RESOURCES WITH ADDITIONAL INFORMATION ABOUT VASCULAR ACCESS DEVICES 603  
     REFERENCES 604  
  Osseointegrated Dental Implants 606  
     INTRODUCTION 606  
     IMPLANT-SUPPORTED PROSTHESES 610  
     TYPICAL CLINICAL RETURN VISIT 614  
     APPENDIX: PARTIAL LIST OF IMPLANT MANUFACTURERS AND SUPPORT GROUPSa 616  
     REFERENCES 617  
  US Counterpoint to Chapter 22 622  
     APPENDIX:SOURCES OF FURTHER INFORMATION ON OSSEOINTEGRATED DENTAL IMPLANTS 625  
     REFERENCES 625  
  European Counterpoint to Chapter 22 627  
     INTRODUCTION 627  
     THE PERI-IMPLANT ENVIRONMENT 628  
     PERI-IMPLANTITIS AND BACTERIAL PLAQUE 628  
     MECHANICAL COMPLICATIONS 629  
     IMPLANT-SUPPORTED PROSTHESES IN THE UNITED KINGDOM 629  
     MAINTENANCE OF DENTAL IMPLANTS 629  
        Prosthetic Factors 630  
        Soft-Tissue Factors 631  
        Bone Factors 631  
        Oral Hygiene Factors 631  
     SUMMARY 632  
     REFERENCES 632  
  Cardiac Pacemakers 635  
     INDICATIONS FOR PACEMAKER THERAPY AND NEED FOR FOLLOW-UP 635  
     THE CLINIC VISIT 638  
     ENVIRONMENTAL EFFECTS ON PATIENTS WITH PACEMAKERS 643  
     REFERENCES 645  
  US Counterpoint to Chapter 23 647  
     INTRODUCTION 647  
     REFERENCES 649  
  European Counterpoint to Chapter 23 651  
     FOLLOW-UP 652  
     MODE SELECTION AND PROGRAMMING 653  
     NEW DEVELOPMENTS 655  
     REFERENCES 655  
  Joint Prostheses and Internal Fixation Devices 657  
     INTRODUCTION 657  
     TYPES OF ORTHOPEDIC BIOMATERIALS 662  
     TOTAL JOINT ARTHROPLASTY 663  
     DETECTION OF FAILURE OF FRACTURE FIXATION DEVICES 665  
     DETECTION OF PROSTHETIC INFECTION 667  
     MANAGEMENT OF THE CONDITION FOR WHICH THE IMPLANT WAS INSERTED 669  
     PREVENTIVE MEASURES 671  
     POSTOPERATIVE FOLLOW-UP 674  
     WHAT HEALTH MAINTENANCE MEASURES ARE WARRANTED? 675  
     APPENDIX: SUPPORT GROUPS AND PATIENT INFORMATION FOR MUSCULOSKELETAL DISEASES 676  
     APPENDIX: SUPPORT GROUPS AND PATIENT INFORMATION FOR MUSCULOSKELETAL DISEASES ( CONTINUED) 677  
     REFERENCES 677  
  US Counterpoint to Chapter 24 681  
     REFERENCES 685  
  European Counterpoint to Chapter 24 688  
     TOTAL JOINT ARTHROPLASTY 688  
     TOTAL JOINT ARTHROPLASTY FAILURE 690  
     IMPLANTS FOR FRACTURE FIXATION 690  
     THROMBOEMBOLIC PROPHYLAXIS 691  
     WHAT HEALTH MEASURES ARE WARRANTED? Arthritis and Total Joint Replacements 692  
     APPENDIX: SOURCES OF ADDITIONAL INFORMATION 692  
     APPENDIX: SOURCES OF ADDITIONAL INFORMATION (CONTINUED) 693  
     REFERENCES 693  
  Index 695  


nach oben


  Mehr zum Inhalt
Kapitelübersicht
Kurzinformation
Inhaltsverzeichnis
Leseprobe
Blick ins Buch
Fragen zu eBooks?

  Medientyp
  eBooks
  eJournal
  alle

  Navigation
Belletristik / Romane
Computer
Geschichte
Kultur
Medizin / Gesundheit
Philosophie / Religion
Politik
Psychologie / Pädagogik
Ratgeber
Recht
Reise / Hobbys
Sexualität / Erotik
Technik / Wissen
Wirtschaft

  Info
Hier gelangen Sie wieder zum Online-Auftritt Ihrer Bibliothek
© 2008-2024 ciando GmbH | Impressum | Kontakt | F.A.Q. | Datenschutz